09-Nov-2026 08:55:00

MOREPEN : LAUNCHES FIRST U.S. PRESCRIPTION GENERIC DESLORATADINE TABLETS

• Desloratadine Tablets USP 5 mg launched in 100-count and 500-count packs for U.S. distribution • Launch undertaken through wholly owned U.S. arm Morepen Bio Inc. • Builds on long-standing Desloratadine API supply to the U.S. market, extending into finished dosage • First ANDA filed with U.S. FDA for Sitagliptin Phosphate Tablets USP 25 mg, 50 mg and 100 mg; under regulatory review • Company intends further U.S. Rx generic filings and may evaluate high-potency APIs and oncology

Morepen Laboratories Limited

← Back to feed